Person: Dr Arlene Ponting

Dr Michael Hayden

Dr Michael Hayden has been appointed president of global R&D and chief scientific officer for Teva Pharmaceutical Industries Ltd, Petah Tikva Israel. Hayden is currently the Canada Research Chair in Human Genetics and Molecular Medicine and Killam professor of medical genetics at the Univ of British Columbia. He is one of the world’s leading experts…

Dr Marie D’Iorio

Dr Marie D’Iorio has been appointed executive director of the National Institute for Nanotechnology (NINT) after serving as its interim DG since last year, following the departure of Dr Nils Petersen. D’Iorio is an expert in nano-electronics and has worked at the National Research Council for nearly 30 years. She was DG of the NRC…

Maurice Bitran

Maurice Bitran has been appointed ADM of the secretariat for the new Ontario Jobs and Prosperity Council (OJPC), effective July 11th. Bitran was most recently assistant DM of the Ministry of Economic Development and Innovation’s strategic policy division, a post he has held since 2009. The OJPC was announced in the last Ontario Budget and…

Dr Arlene Ponting

Dr Arlene Ponting is stepping down as CEO of the Science Alberta Foundation (SAF) after 13 years. Ponting will retire this December. She was instrumental in turning SAF into an award-winning science education organization aimed at youth….